CB Insights
Technology Market Intelligence
Technology Market Intelligence
Hummingbird Bioscience is a biotherapeutics company focused on the discovery and development of precision antibody therapeutics for difficult-to-treat conditions. Leveraging its proprietary rational antibody discovery platform and deep experience in ...Show all
Company (Alive / Active)
Phone:
Temasek Lifescience Laboratories
1 Research Link
117604
Singapore
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|---|---|---|
| Cancer Prevention and Research Institute of Texas | Government | Austin, Texas, United States | Grant |
| Decheng Capital | Venture Capital | Menlo Park, California, United States | Series A |
| Delian Capital | Venture Capital | Beijing, Beijing, China | Series B |
| G.N. Tech Venture Capital | Corporate Venture | Seoul, South Korea | Series B |
| DA Value Investment | Venture Capital | Seoul, South Korea | Series B |
| Name | Firm |
|---|---|
| Login to see details | Decheng Capital |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Her3 antigen-binding molecules | Oct 08, 2019 | May 26, 2020 | Patent |
| Vista antigen-binding molecules | Oct 08, 2019 | Apr 28, 2020 | Patent |
| Vista antigen-binding molecules | Mar 18, 2020 | Application | |
| Her3 antigen-binding molecules | Feb 28, 2020 | Application | |
| Vista antigen-binding molecules | Nov 05, 2018 | Application |
